Skip to main content
Log in

High performances of 18F-fluorodeoxyglucose PET-CT in cardiac implantable device infections: A study of 40 patients

  • Original Article
  • Published:
Journal of Nuclear Cardiology Aims and scope

An Erratum to this article was published on 04 June 2015

Abstract

Background

Cardiovascular implantable electronic devices (CIED) infections are life-threatening complications. The diagnosis can be difficult to establish. Our purpose is to evaluate the diagnostic value of 18F-FDG PET.

Methods

Forty patients who received work-up for suspected CIED infection were retrospectively included (group 1) and compared with 40 controls (group 2); CIED patients were referred for oncologic PET. PET-CT data were blindly assessed. Interpretation was based on visual analysis of both attenuation-corrected and non-corrected images and a semi-quantitative analysis was performed. The gold standard was bacteriological data of explanted devices or clinical follow-up for at least 1 year.

Results

Infection was present in 18 out of 40 patients of group 1. Sensitivity, specificity, positive predictive value, and negative predictive value of PET-CT were 83%, 95%, 94%, and 88%, respectively. Accuracy was 90%. PET-CT revealed the presence of additional pathological hypermetabolic foci in 28% of cases. PET-CT was negative at implanted devices in all patients of group 2.

Conclusion

18F-FDG PET-CT is helpful in the work-up of suspected CIED infections. It is a potential tool to make the accurate diagnosis of CIED infection and to assess the extent of infection. The promising results in this indication need to be validated in a prospective multicenter study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Uslan DZ, Baddour LM. Cardiac device infections: Getting to the heart of the matter. Curr Opin Infect Dis 2006;19:345-8.

    Article  PubMed  Google Scholar 

  2. Glaudemans AW, de Vries EF, Galli F, Dierckx RA, Slart RH, Signore A. The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. Clin Dev Immunol 2013. doi:10.1155/2013/623036.

    PubMed Central  PubMed  Google Scholar 

  3. Haroon A, Zumla A, Bomanji J. Role of fluorine 18 fluorodeoxyglucose positron emission tomography-computed tomography in focal and generalized infectious and inflammatory disorders. Clin Infect Dis 2012;54:1333-41.

    Article  CAS  PubMed  Google Scholar 

  4. Bensimhon L, Lavergne T, Hugonnet F, Mainardi JL, Latremouille C, Maunoury C, et al. Whole body [(18) F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: A preliminary prospective study. Clin Microbiol Infect 2011;17:836-44.

    Article  CAS  PubMed  Google Scholar 

  5. Ploux S, Riviere A, Amraoui S, Whinnett Z, Barandon L, Lafitte S, et al. Positron emission tomography in patients with suspected pacing system infections may play a critical role in difficult cases. Heart Rhythm 2011;8:1478-81.

    Article  PubMed  Google Scholar 

  6. Sarrazin JF, Philippon F, Tessier M, Guimond J, Molin F, Champagne J, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol 2012;59:1616-25.

    Article  PubMed  Google Scholar 

  7. Cautela J, Alessandrini S, Cammilleri S, Giorgi R, Richet H, Casalta JP, et al. Diagnostic yield of FDG positron-emission tomography/computed tomography in patients with CEID infection: A pilot study. Europace 2013;15:252-7.

    Article  PubMed  Google Scholar 

  8. Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: Temporal trends and causative insights. Pacing Clin Electrophysiol 2010;33:414-9.

    Article  PubMed  Google Scholar 

  9. Brinker J. Imaging for infected cardiac implantable electronic devices: A new trick for your pet. J Am Coll Cardiol 2012;59:1626-8.

    Article  PubMed  Google Scholar 

  10. Leccisotti L, Perna F, Lago M, Leo M, Stefanelli A, Calcagni ML, et al. Cardiovascular implantable electronic device infection: Delayed vs standard FDG PET-CT imaging. J Nucl Cardiol 2014;42:623-8.

    Google Scholar 

  11. Erba PA, Sollini M, Conti U, Bandera F, Tascini C, De Tommasi SM, et al. Radiolabeled WBC scintigraphy in the diagnosic workup of patients with suspected device-related infections. J Am Coll Cardiol Cardiovasc Imaging 2013;6:1075-86.

    Article  Google Scholar 

  12. Chen W, Kim J, Molchanova-Cook OP, Dilsizian V. The potential of FDG PET/CT for early diagnosis of cardiac device and prothetic valve infection before morphologic damages ensue. Curr Cardiol Rep 2014;16:459.

    Article  PubMed  Google Scholar 

  13. Israel O, Keidar Z. PET/CT imaging in infectious conditions. Ann N Y Acad Sci 2011;1228:150-66.

    Article  PubMed  Google Scholar 

  14. Bertagna F, Bisleri G, Motta F, Merli G, Cossalter E, Lucchini S, et al. Possible role of F18-FDG-PET/CT in the diagnosis of endocarditis: Preliminary evidence from a review of the literature. Int J Cardiovasc Imaging 2012;28:1417-25.

    Article  PubMed  Google Scholar 

  15. Millar BC, Prendergast BD, Alavi A, Moore JE. 18 FDG-positroon emission tomography (PET) has a role to play in the diagnosis and therapy of infective endocarditis and cardiac device infection. Int J Cardiol 2013;167:1724-36.

    Article  PubMed  Google Scholar 

  16. Harisankar CN, Mittal BR, Agrawal KL, Abrar ML, Bhattacharya A. Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake. J Nucl Cardiol 2011;18:926-36.

    Article  PubMed  Google Scholar 

  17. Ahmed FZ, James J, Tout D, Arumugam P, Mamas M, Zaidi AM. Metal artefact reduction algorithms prevent false positive results when assessing patients for cardiac implantable electronic device infection. J Nucl Cardiol 2015;22:219-20.

    Article  PubMed  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Laurence Bordenave MD, PhD.

Additional information

See related editorial, doi:10.1007/s12350-015-0102-y.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tlili, G., Amroui, S., Mesguich, C. et al. High performances of 18F-fluorodeoxyglucose PET-CT in cardiac implantable device infections: A study of 40 patients. J. Nucl. Cardiol. 22, 787–798 (2015). https://doi.org/10.1007/s12350-015-0067-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-015-0067-x

Keywords

Navigation